Clinical Trials Directory

Trials / Completed

CompletedNCT04667338

A Study to Collect Information of People With Narcolepsy in Spain

Observational, Multicentre, Cross-sectional Study to Describe Diagnosis and Treatment Patterns in Narcolepsy Patients in Real Life Practice in Spain

Status
Completed
Phase
Study type
Observational
Enrollment
214 (actual)
Sponsor
Takeda · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to review information of people with a sleep condition called narcolepsy. Narcolepsy is a condition that causes extreme sleepiness during the day including falling asleep suddenly. Study doctors will review the medical records of the participants from sleep clinics in Spain. They will do this from 1 year before the participant was diagnosed with narcolepsy up to the start of this study. Participants will visit the sleep clinic once. During this visit, the study doctors will carry out a short medical exam. Participants will also complete a few questionnaires during this visit. If participants cannot visit the clinic for any reason, the clinic staff will arrange a phone call instead.

Detailed description

This is a non-interventional, cross-sectional study with retrospective medical chart review conducted in public and private Spanish sleep clinics, to describe the management of adult participants diagnosed with narcolepsy defined by ICDS-3 in real world practice. This study will enroll approximately 196 participants (137 with NT1 and 59 with NT2). Participants will be enrolled in 2 cohorts: * Cohort A: NT1 Participants * Cohort B: NT2 Participants The data will be collected retrospectively through clinical records and at study visit (clinical and demographic data, and participant related outcomes \[PRO\]) in an electronic case report form (eCRF). This multi-center study will be conducted in Spain. The overall duration of this study is approximately 24 months. Participants will attend a single visit in the participating centers. In the event of a possible outbreak of coronavirus disease 2019 (COVID-19) participants will have a telepathic visits, the invitation to participate, the obtention of participant's informed consent and the collection of participant's questionnaires will be carried out remotely (by phone or via email).

Conditions

Timeline

Start date
2021-02-18
Primary completion
2022-11-04
Completion
2022-11-04
First posted
2020-12-14
Last updated
2024-10-04
Results posted
2024-10-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04667338. Inclusion in this directory is not an endorsement.